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Abstract: 
The cytochromes P450 (CYPs) play a central role in many biologically 
important oxidation reactions, including the metabolism of drugs and other 
xenobiotic compounds. Because they are often assayed as both drug targets 
and anti-targets, any tools that provide: (a) confirmation of active site 
binding and (b) structural data, would be of great utility, especially if data 
could be obtained in reasonably high throughput. To this end, we have 
developed an analog of the promiscuous heme ligand, cyanide, with a 13CH3-
reporter attached. This 13C-methyl isocyanide ligand binds to bacterial 
(P450cam) and membrane-bound mammalian (CYP2B4) CYPs. It can be used 
in a rapid 1D experiment to identify binders, and provides a qualitative 
measure of structural changes in the active site. 
Keywords: NMR, Heme, P450cam, CYP2B4, Screening. 
Introduction 
The cytochromes P450 (CYPs) are a family of heme-containing 
monooxygenase enzymes that use molecular oxygen to hydroxylate 
specific substrates, often with high stereoselectivity (Poulos and 
Johnson 2005). While CYPs are present in both eukaryotes and 
prokaryotes, the prokaryotic enzymes are soluble and therefore easier 
to study. A prototypical and well-studied bacterial CYP is P450cam 
(CYP101), from Pseudomonas putida (Katagiri et al. 1968; Poulos et 
al. 1986). P450cam is a 46 kDa soluble enzyme that catalyzes the 5-
exo-hydroxylation of camphor (Gelb et al. 1982). A prototypical and 
well-studied mammalian CYP is CYP2B4. CYP2B4 is a 55 kDa 
membrane-bound protein from rabbit liver that either hydroxylates or 
demethylates a variety of foreign compounds, such as the drug 
benzphetamine (Kanaeva et al. 1992). The mammalian CYPs, being 
the enzymes predominantly responsible for drug and xenobiotic 
metabolism in humans, are of particular interest in the pharmaceutical 
industry. They are relatively large, membrane-bound proteins with a 
typical molecular weight of ~65 kDa (Furge and Guengerich 2006). 
Consequently, it is difficult to obtain structural information on the 
mammalian CYPs, either via X-ray or current multidimensional NMR 
techniques. Although, there have been some recent successes in 
crystallizing mammalian CYPs that lack the membrane-binding N-
terminal region, and have other solubilizing mutations (Williams et al. 
2000; Williams et al. 2003; Williams et al. 2004; Scott et al. 2003). 
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But, the mammalian CYPs are too large to structurally characterize 
with NMR, and membrane-bound CYPs have yet to be crystallized. 
Hence, there is a need to develop new techniques that rapidly probe at 
least part of the active site structure, to better define binding 
interactions with substrates or inhibitors. 
With the above goal in mind, we have decided to capitalize on 
the fact that cyanide is a promiscuous ligand for heme iron (binding 
through its carbon), and that alkyl isocyanides (alkyl-NC) are known to 
be ligands for a number of CYPs (Tomita et al. 2001; Lee et al. 2001). 
Their absorption spectra are typical of Type II binding spectra, where 
the Soret band is shifted upon binding of the alkyl isocyanide, with 
absorption maxima occurring at either or both 430 and 455 nm, 
depending upon the extent of back-bonding from iron into the isonitrile 
triple bond. Indeed, resonance Raman experiments (Tomita et al. 
2001; Lee et al. 2001) have established that the heme-bound 
isocyanide binds in two distinct orientations, linear or bent depending 
on C–Fe bond order; these forms are in slow exchange on the 
resonance Raman timescale, but would normally be in fast exchange 
on the NMR timescale. These two orientations are illustrated in Fig. 1, 
for the methyl isocyanide ligand that is the topic of this paper. The 
linear and bent forms are related to the two resonance forms of 
methyl isocyanide (Scheme 1), although the imine form is highly 
disfavored unless there is electron donation to stabilize it via formation 
of a dative bond (as in Fig. 1; in this case, electron donation is via 
backbonding from the iron). 
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Fig. 1 Methyl isocyanide bound to the heme iron. Schematic representation of 
methyl isocyanide bound to heme with (a) an iron-carbon bond order of two (“bent”) 
and (b) an iron-carbon bond order of one (“linear”). The heme pyrrole rings, along 
with the CN triple (or double) bond, produce a highly anisotropic environment that can 
produce large chemical shift perturbations for the labeled methyl group 
 
Scheme 1 Resonance structures for methyl isocyanide 
Alkyl isocyanides bind particularly strongly when the iron of the 
heme is in its reduced form (Kd ~ 10–5–10–6 M), although it can be 
shown that with increasing alkyl chain length, even the ferric form can 
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exhibit dissociation constants in the micromolar range (Simonneaux 
and Bondon 2000). 
Given the established value of 13CH3-methyl probes for NMR 
structural and dynamical studies of large proteins (Pellecchia et al. 
2002; Showalter et al. 2007; Tugarinov et al. 2006), our interest in 
alkyl isocyanides is limited to methyl isocyanide (13CH3NC). As the 
smallest member of the alkyl isocyanides, it is the one least likely to 
interfere with substrate or inhibitor binding (being only slightly larger 
than the native ligand, dioxygen). Also, the lack of adjacent methylene 
protons avoids dipolar relaxation effects, which would lead to line 
broadening. The 13C-label allows for selective observation of the 
attached methyl protons, which provides a chemical shift perturbation 
probe of structural (and potentially dynamical) changes in the binding 
pocket, due to binding of substrate or inhibitor. Moreover, because of 
the short internal correlation time of the rapidly rotating methyl group, 
even when bound to the heme, the proton linewidth should remain 
narrow—like those of a small molecule. Taken together, these features 
potentially allow structural and dynamic information to be extracted 
from NMR experiments such as: 2D 1H-13C HSQC, 13C-filtered 1H 1D, 
13C-edited (or filtered) NOESY, methyl dynamics (ex. using 13CHD2, 
13CH2D (Showalter et al. 2007; Cavanagh et al. 2007), and various 
other experiments (Cavanagh et al. 2007). Given the large size of CYP 
enzymes, especially when complexed to micelles, most of these NMR 
experiments would not normally be feasible. Herein is presented the 
synthesis, initial characterization and application of the 13C-methyl 
isocyanide probe, to enable such studies. This probe will permit the 
first such targeted NMR studies of CYP binding sites, and provide 
evidence for active site changes near the heme, due to the presence or 
absence of substrates, inhibitors or other cellular components, 
especially lipids or electron donating protein partners. 
Materials and methods 
CYP2B4, myoglobin and biochemical reagents 
Myoglobin (horse heart, >90% pure), benzphetamine, DEAE 
resin, and other reagents were from Sigma-Aldrich, unless specified 
otherwise. CYP2B4 was expressed in C41 E. coli cells using the pLW01-
P450 2B4 mem plasmid, and purified as described previously (Miroux 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Biomolecular NMR, Vol. 43, No. 3 (2009): pg. 171-178. DOI. This article is © Springer and permission has been 
granted for this version to appear in e-Publications@Marquette. Springer does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Springer. 
6 
 
and Walker 1996; Bridges et al. 1998). 13C-methyl iodide and d8-
glycerol were from Isotec, and d38-DPC (dodecylphosphocholine-d38) 
was from Cambridge Isotope Laboratories. 
Expression and purification of P450cam 
P450cam was expressed in E. coli (BL21DE3*) using a pCWori 
expression construct (a kind gift from Dr. Paul Ortiz de Montellano) 
and purified largely as described previously (Sibbesen et al. 1996; Yao 
et al. 2007), with some changes to the protocol. Briefly, 6 L of cell 
culture were grown at 37°C in 1 L batches to an OD600 of 0.7–0.9, 
before adding 1 mM IPTG (Isopropyl-β-D-Thiogalactopyranoside) for 
induction and 30 μM δ-ALA (δ-aminolevulinic acid) as a heme 
precursor, and allowing protein expression to continue for 20–22 h. 
After the cells were harvested they were frozen at –80°C for several 
hours, before resuspending in lysis buffer (50 mM Tris*HCl, pH 7.5 
(room temp.), 25 mM KCl, 1–2 mM camphor, 1 mM EDTA, 1 mM 
PMSF, 1 lM leupeptin, 1 μM pepstatin, 32 U/ml DNase, 3 U/ml RNase, 
1 mg/ml lysozyme) and sonicating. The cell debris was spun down at 
50,000g and the supernatant was collected to be loaded onto a 50-ml 
bed volume DE-52 anion exchange column that had been pre-
equilibrated with running buffer (50 mM Tris*HCl, pH 7.5 (4°C), 25 
mM KCl, 2 mM camphor). After washing with two column volumes of 
running buffer, protein was eluted using a linear gradient from 0 to 
100% of elution buffer (50 mM Tris*HCl, pH 7.5 (4°C), 300 mM KCl, 2 
mM camphor). All fractions with an RZ ratio (A392/A280) > 0.5 were 
pooled and concentrated. 
Ammonium sulfate was added to the pooled fractions to 25% 
saturation (~143 mg/ml), and they were then loaded onto a phenyl 
sepharose column (50 ml bed volume), after it had been pre-
equilibrated with running buffer (50 mM Tris*Cl, pH 7.5, 50 mM KCl, 
25% NH4SO4, 100 μM camphor). After washing, elution was achieved 
with a linear gradient of 0 to 100% of elution buffer (50 mM Tris*HCl 
(pH 7.5), 50 mM KCl, 1 mM camphor). All fractions having an Rz ratio 
≥ 1.4 were pooled, and purity was confirmed with an SDS gel 
(Supplementary Fig. S1). Protein (500 μM) was dialyzed into 30 mM 
phosphate buffer (pH 7.4), 100 mM KCl, 2 mM camphor, and flash 
frozen in 12 1-ml aliquots and stored at –80°C. Typical yield was ~ 
100 mg/6 L cell culture. 
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Synthesis of 13C-methyl isocyanide (13CH3NC) 
13CH3NC was synthesized with modifications to a previously 
reported procedure (Freedman and Nixon 1972). 1 mmol of 13C-methyl 
iodide and 2 mmol of silver cyanide were placed in a thick walled glass 
tube and sealed. The mixture was heated for 1 h at 95°C in an oil bath 
and the tube was then brought to room temperature slowly. The 
sealed tube was opened and the brown solid was quenched for 12 h in 
5 ml of an 8 M KCN solution. The resultant mixture was distilled under 
vacuum to obtain crude 13C-methyl isocyanide, which was purified by 
bulb-to-bulb distillation. Yield was 21%, and the 1H NMR spectrum 
(Fig. 2) confirmed the structure. The pair of 1:1:1 triplets resulting 
from 13C-1H scalar coupling (1J coupling, producing the large doublet) 
and 14N-1H scalar coupling (2J coupling, producing the triplet) was only 
apparent in d4-methanol and D2O; in other solvents that were used, 
including d3-acetonitrile, d1-chloroform and d6-benzene, the spectrum 
only showed the large doublet splitting from the 13C-1H coupling. The 
proton chemical shift also varied depending upon the solvent used, 
and generally shifted upfield with increasing nonpolarity of the solvent 
(for example, the methyl protons had a chemical shift of 1.1 ppm in 
d6-benzene). 
 
Fig. 2 NMR spectrum of 13C-methyl isocyanide in d4-methanol. The 
13C-coupled 1H resonances from 13CH3NC flank the solvent resonance. 
The inset shows the further splitting (1:1:1 triplet) of the two 13C-split 
proton resonances. This triplet splitting is due to 2J coupling between 
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the quadrupolar 14N nucleus (I = 1) and the methyl protons. Spectrum 
acquired at 300 MHz 
NMR spectral analysis of 13CH3NC bound to heme 
proteins 
All NMR spectra were collected at 25°C on a 600 MHz Varian 
spectrometer equipped with a triple-resonance cryoprobe. 1H-13C 
HSQC spectra were collected with a spectral width of 12,000 and 
28,000 Hz and digitized with 1920 and 256 complex points for the 1H 
and 13C dimensions, respectively. Spectra were referenced directly to 
H2O (δ = 4.76 ppm at 25°C) in the 1H dimension and indirectly in the 
13C dimension. For the samples with P450cam as the heme protein, 
the protein concentration was 150 lM, as confirmed 
spectrophotometrically, using an extinction coefficient of 105 μM–1 cm–
1 for the Fe3+-substrate free protein with λmax = 418 nm (O'Keeffe et 
al. 1978). Buffer conditions were 30 mM potassium phosphate (pH 
7.4), 100 mM KCl, with saturating camphor (for samples that 
contained substrate) at 2 mM. When CYP2B4 was used as the heme 
protein, the concentration was 75 μM, determined using the extinction 
coefficient for the CYP2B4-CO complex of Δε450–490 = 91 mM–1 cm–1 
(Omura and Sato 1964). Buffer was 100 mM potassium phosphate (pH 
7.4) with either 20% (v/v) d8-glycerol or 50 mM d38-DPC, with 
maximum benzphetamine concentrations (for samples that contained 
substrate) of 1.6 mM, close to its solubility limit at pH 7.4. All samples, 
after having argon gas bubbled through the solution for 15 min to 
purge any oxygen, were reduced with dithionite, followed by addition 
of an equimolar amount of 13CH3NC to form the ferrous heme protein-
13CH3NC complex. 
Results and discussion 
Synthesis and characterization of 13CH3NC: coupling to 
14N and effects of solvent polarity 
The 13CH3NC probe was prepared from 13C-methyl iodide and 
silver cyanide. Surprisingly, the proton NMR spectrum reveals that in 
some solvents (esp. polar solvents), a 2-bond coupling to the cyanide 
14N atom is present. Such coupling to nitrogen is not typically observed 
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due to quadrupolar relaxation from 14N (which is I = 1). But the axial 
symmetry of the molecule, along with a very short correlation time, 
appears to be decreasing the extent of quadrupolar relaxation. This is 
because the quadrupolar relaxation rate is proportional to the 
correlation time, and also has a squared dependence on the 
asymmetry parameter η = (EXX – EYY)/EZZ (Nelson 2003), which should 
be zero (EXX – EYY = 0) for an axially symmetric molecule like CH3NC. 
Perhaps in nonpolar solvents, where this coupling is no longer 
observed, there is some sort of intermolecular interaction between 
molecules that breaks this symmetry (EXX – EYY ≠ 0), thereby restoring 
the quadrupolar relaxation effects that usually decouple 14N coupling. 
In this regard, it is interesting that gas phase (argon matrix) infrared 
spectroscopy studies (Freedman and Nixon 1972) have indicated that 
methyl isocyanide forms a dimer, whereby the large CN dipoles (see 
the isonitrile resonance structure in Scheme 1) align in an antiparallel 
orientation. Such pairing to neutralize dipole moments might also be 
favored in a nonpolar solvent, and could produce an upfield shift for 
the methyl protons, as shown in Scheme 2. 
 
Scheme 2 Proposed methyl isocyanide dimer in nonpolar solvent 
However, the situation could certainly be different in solution 
relative to the gas phase. One must also consider the possibility of 
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higher order structures, at least in solution, and even cyclic trimers 
that might form due to stabilizing dative bonds between molecules in 
the imine resonance form, shown in Scheme 1. Whatever the source of 
this interesting phenomenon, it is not relevant for protein studies, 
since the 14N coupling is no longer observed when 13CH3NC is bound to 
heme iron. 
Application of the 13CH3NC probe to studies of a 
bacterial CYP: P450cam 
Initial studies were done with cytochrome P450cam (P450cam) 
which, being a soluble and well-studied P450 protein, serves as an 
excellent model system. In Fig. 3a is shown the 1H-13C HSQC spectrum 
of 13C-labeled methyl isocyanide (13CH3NC) in buffer, without protein 
present. The appearance of the spectrum is the same in the presence 
or absence of camphor, indicating that no significant interactions occur 
between substrate and probe in solution, in the absence of P450cam. 
The 1H-13C HSQC spectrum of 13CH3NC in the presence of an equimolar 
concentration of reduced (ferrous) P450cam (Fig. 3b) shows a large 
upfield shift due to heme binding. The signal of free 13CH3NC has 
disappeared and a new signal with a 1Hδ of 1.2 ppm and 13Cδ of 21.4 
ppm has appeared. The upfield shift in both dimensions presumably 
reflects the fact that the methyl group of the probe, when bound to 
the heme-iron, now sits directly above the aromatic porphyrin ring, 
resulting in increased shielding of the relevant resonances due to ring 
current effects (Fig. 1). Figure 3c is a spectrum of the same sample 
shown in Fig. 3b, but now with excess 13CH3NC, clearly showing that 
the free and bound forms are in slow exchange on the chemical shift 
timescale. Finally, the 1H-13C HSQC spectrum of the 13CH3NC/Fe2+-
P450cam/camphor ternary complex (Fig. 3d) reveals two new major 
crosspeaks (and a third less intense resonance), distinct from both 
free and bound (- camphor). It appears therefore that camphor is 
either binding in two orientations, or that the probe itself occupies two 
major orientations (possibly linear and bent, but now in slow exchange 
on the NMR timescale, due to steric clash with camphor?). In any case, 
this experiment clearly identified camphor as binding in the active site, 
thereby validating the use of 13CH3NC for identifying such molecules in 
NMR-based screening. 
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Fig. 3 P450cam 1H-13C HSQC spectra showing (a) unbound 13CH3NC, (b) 
stoichiometric 13CH3NC bound to Fe2+-P450cam, (c) 13CH3NC bound to Fe2+-P450cam 
in the presence of excess 13CH3NC, and (d) 13CH3NC bound to Fe2+-P450cam in the 
presence of a saturating amount of camphor. The additional peaks in panels B, C, and 
D at 60–75 ppm are due to natural abundance glycerol 1H-13C signal 
Application of the 13CH3 NC probe to studies of a 
mammalian CYP: CYP2B4 
The same binding studies were done with native, full-length 
CYP2B4 in 100 mM potassium phosphate buffer (pH 7.4) and 20% 
(v/v) d8-glycerol (see Fig. S2). This time, upon addition of an 
equimolar amount of CYP2B4, the bound form of the 13CH3NC probe 
had a 1Hδ of 3.13 ppm and a 13Cδ of 76.8 ppm. That is, there is now a 
dramatic downfield shift for carbon (but not hydrogen). When 
substrate (benzphetamine) was then added, the methyl crosspeak 
shifted to have a 1Hδ of 3.13 ppm and a 13Cδ of 49.5 ppm. The 
chemical shifts of the unbound 13CH3NC probe (not shown) are the 
same as those reported above, in the absence of d8-glycerol (Fig. 3a). 
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These data indicate that 13CH3NC is an extremely sensitive chemical 
shift probe that can be used to identify occupancy of active sites for 
solubilized mammalian CYPs like CYP2B4. 
While the above studies are of great value for identifying active 
site binders, they still suffer from the same limitations that most 
structural studies of mammalian CYPs do—they are of the enzyme in a 
relatively artificial state, unbound to lipid. Because CYP2B4 is normally 
bound to a phospholipid bilayer in vivo, we repeated the above 
experiments, but now in the presence of d38-DPC micelles. In the 
control spectrum taken in the absence of both protein and substrate, 
there now appeared a new peak for the methyl of 13CH3NC, in addition 
to the one previously observed for free 13CH3NC (Fig. 3a). This new 
resonance is shifted upfield in the proton dimension with a 1Hδ of 1.17 
ppm, but is largely unchanged in the carbon dimension (13Cδ of 30.3 
ppm). This new peak is likely due to 13CH3NC that has been taken up 
into the nonpolar interior of the micelle, and is similar to the chemical 
shift change we saw for probe in nonpolar solvents like d6-benzene 
(vide supra). When CYP2B4 protein is then added, one new peak 
appears, presumably from 13CH3NC that binds the heme iron of 
micelle-bound CYP2B4. This peak is upfield shifted (Table 1). Finally, 
when benzphetamine was added, the intensity of this crosspeak 
decreased and three new peaks appeared with 1Hδs of 2.64, 2.73 and 
2.80 ppm and 13Cδs of 37.5, 27.15 and 38.5 ppm, respectively (Table 
1). These data suggest that 13CH3NC-bound CYP2B4 can bind 
benzphetamine, and that multiple conformations exist for this 
CYP2B4:13CH3NC:benzphetamine ternary complex. Most importantly, 
these chemical shift changes are very different than what was 
observed for the free CYP2B4 (with glycerol present), indicating at 
least qualitatively that the heme is in a very different electronic state 
when CYP2B4 is bound to micelles versus when it is solubilized with 
glycerol. Currently, there are no structural methods to probe active 
site changes in mammalian CYPs, due to binding to lipid. Given that all 
current crystal structures are of free CYPs, it is therefore vitally 
important to determine if the active site structure changes in the 
presence of lipid. 
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Table 1 1H-13C HSQC crosspeak chemical shifts for various 13CH3NC complexes 
*Buffer A: 100 mM KCl, 30 mM potassium phosphate, pH 7.4; Buffer B: 20% (v/v) 
glycerol, 100 mM potassium phosphate, pH 7.4; Buffer C: 50 mM DPC, 100 mM 
potassium phosphate, pH 7.4 
Application of 13CH3NC probe using 1D spectra—
towards higher throughput 
The above studies establish the utility of the 13CH3NC probe for 
screening to identify molecules that bind in CYP active sites. But, 2D 
1H-13C HSQC experiments are too time-consuming (1–4 h) for higher 
throughput screening efforts, especially if lower protein concentrations 
are used (≤150 μM). Fortunately, since only one crosspeak is being 
monitored, 2D experiments are not necessary. Instead, a much 
shorter 13C-filtered 1H 1D spectrum (Fig. 4) could be acquired, or a 13C 
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1D using a cryoprobe with cryocooled 13C preamp (Kovacs et al. 
2005), depending upon whether the change of interest is occurring in 
the 1H or the 13C dimension. This, coupled with the fact that very little 
chemical probe is actually needed (~5 μg for a 0.5 ml sample of 250 
μM protein), makes its use in a high-throughput assay even more 
attractive, as it should be able to provide reliable, fast and inexpensive 
information about a compound's ability to bind to a given heme 
protein. Furthermore, advances in microflow probe technology (Olson 
et al. 2004) would permit assays to be done on volumes as low as 10 
μl, making such screening even more feasible in terms of protein 
consumption (requiring only ~100 μg protein/assay, so ~10 mg to 
screen a 96-well plate of compounds), at least as a secondary assay. 
Of course, since protein concentration would be ~150 μM, one would 
need to have at least 50 νM of the compound to be screened present 
to see a significant effect on the methyl chemical shift. Finally, 
subsequent use of the 13CH3NC probe to obtain structural information 
from NOE data will be limited to molecules that bind in fast exchange 
(i.e. using transferred NOE experiments), because it is usually not 
practical to obtain concentrated solutions of mammalian CYP enzymes, 
given their hydrophobic nature. 
 
Fig. 4 13C-filtered 1H 1D spectra of (a) unbound 13CH3NC and (b) 13CH3NC bound to 
Fe2+-P450cam 
Interpretation of chemical shift changes 
Besides the qualitative information on a compound's ability to 
bind to CYP active sites, the magnitude of the chemical shift 
perturbations could possibly be used to calculate a binding orientation 
for the probe relative to the central heme iron, and the largely planar 
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and aromatic porphyrin ring system (Fig. 1). Furthermore, anisotropy 
effects from a bound CYP substrate or inhibitor (which are often 
aromatic) could help to position it relative to probe. Indeed, chemical 
shift values are increasingly being used to refine protein structures (Xu 
and Case 2001). Unfortunately, these algorithms are not adequately 
parameterized at present to deal properly with the highly anisotropic 
effects from the CH3NC triple bond, the heme pyrrole rings and the 
diverse array of aromatic ring systems likely to be present in CYP 
substrates or inhibitors. 
At one level, since it is reasonable to assume the dominant 
resonance structure of 13CH3NC free in solution is the isonitrile 
(Scheme 1), then any deviation of the 1Hδ from that of its unbound 
solution form must be due to effects from the heme anisotropy and/or 
from increasing the population of the bent orientation. In the case of 
CYP2B4 in 20% glycerol, the 1Hδ remained the same as that of the 
unbound probe, both in the absence and presence of saturating 
amounts of substrate, while the 13Cδ was first shifted dramatically 
downfield ~45 ppm and then back upfield ~25 ppm, still distant from 
its original position. One possible interpretation of these unusual shifts 
is that, due to the structural/steric constraints of the binding pocket 
(or heme electronic changes leading to more backbonding), the probe 
is forced to adopt a more bent orientation relative to the porphyrin 
ring. It is surprising, though, that the methyl protons wouldn't shift 
downfield like the methyl carbon does, if the change is simply due to a 
more bent orientation. The reasons for these large chemical shift 
changes are not entirely clear, but will be a function of: (a) the high 
level of anisotropy coming from the heme pyrrole rings and the 
cyanide triple bond (Fig. 1), (b) the extent of backbonding from iron (a 
function of heme electronic state), which would alter the relative 
population of the linear and bent forms of the probe, (c) the physical 
perturbation/steric clash between a substrate or inhibitor and the 
13CH3NC probe, which could also alter the relative population of linear 
and bent forms (and its position in this highly anisotropic 
environment), and (d) any anisotropic effects from the 
substrate/inhibitor itself, if it has aromatic rings as benzphetamine 
does. The combination of these effects would make any structure-
based calculation of chemical shift changes difficult at present, but 
clearly the probe's unique position in a highly anisotropic environment 
makes it exquisitely sensitive to even modest structural or electronic 
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perturbations, and thereby makes it a very sensitive chemical shift 
probe. As a final point on structural inferences that could be made, it 
is tempting to speculate that when the probe gives two new 
crosspeaks for a complex with substrate or inhibitor, this might 
indicate a steric clash is occurring, which slows the exchange between 
the linear and bent structures (Scheme 1 and Fig. 1). The data with 
camphor bound to P450cam and benzphetamine bound to micelle-
bound CYP2B4 are consistent with this interpretation, but more 
experiments are needed to prove that this is in fact the source of the 
multiple crosspeaks. 
Application of the13CH3 NC probe to other heme 
proteins: myoglobin 
Regardless of the actual underlying structural changes occurring 
within these CYP complexes, and the source of the chemical shift 
changes, the NMR data do indicate that the 13CH3NC probe will be 
useful as a screening tool for monitoring active site changes in CYPs. 
But, might the probe also be useful for exploring other heme proteins, 
beyond the CYPs? As a first step towards answering this question, 
spectra of 13CH3NC bound to 500 μM myoglobin (a non-P450 heme 
protein) have been obtained (Fig. S3), and they show a similar upfield 
chemical shift in both 1H and 13C dimensions. This suggests the probe 
might be useful for studying other heme protein active sites as well. 
In summary, we have developed 13CH3NC as the first NMR-
based probe of cytochrome P450 active sites. This probe binds to both 
bacterial and mammalian P450s, even membrane-bound P450s, and 
may have broader utility with other heme proteins. It can be used to 
detect structural and electronic changes in active sites. In particular, it 
can be used to screen for P450 substrates or inhibitors using a 
reasonably high throughput assay, by acquiring a simple 13C-filtered 
1D spectrum and monitoring chemical shift changes for the methyl 
protons. Since this could be done with microflow NMR (ex. Protasis 
CapNMR) at volumes as low as ~10 μl, the assay would consume only 
~100 μg protein, making it reasonably sensitive for an NMR assay. 
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Supplementary Material 
Supplementary Data 
 
Figure S1.  SDS-PAGE gel electrophoretic analysis of P450cam expressed in E. 
coli.  Lane 1 contains crude cell lysate; lanes 2 & 4 contain the final purified protein (Rz 
= 1.4) with protein concentration in lane 4 two-fold higher than that in lane 2; lane 3 
contains pooled protein fractions eluted after the first purification step (DE52 column); 
and lane 5 contains standards with molecular weights of 15, 25, 35, 50, 75, 100, and 
150 kDa, respectively (bottom to top). 
 
 
Figure S2. CYP2B4 1H-13C HSQC spectra showing (A) 13CH3NC bound to Fe2+-
CYP2B4, or (B) 13CH3NC bound to Fe2+-CYP2B4 in the presence of 1.6 mM 
benzphetamine. The additional peaks are due to natural abundance glycerol signal. 
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Figure S3. (A) 1H-13C HSQC and (B)  13C-filtered 1H 1D spectrum of excess 
13CH3NC bound to Fe2+-myoglobin. 
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Abbreviations 
δ-ALA δ-Aminolevulinic acid 
cam Camphor 
CYP Cytochrome P450 
DEAE Diethylaminoethyl 
DPC Dodecylphosphocholine 
EDTA Ethylenediaminetetraacetic acid 
HSQC Heteronuclear single quantum coherence 
IPTG Isopropyl-β-D-thiogalactopyranoside 
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PMSF Phenylmethanesulonyl fluoride 
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